Novel CCR5 Antagonist for the Treatment of Mild-Moderate COVID-19 Infection after Lung Transplant

por Skendelas, J.P., Phan, D., Caputo, V., Stryker, K., Ahmed, S., Philippsborn, P., Thalappillil, J., Scheinin, S.A., Seethamraju, H.
Publicado 2021